- The ASRS v1.1 is an 18-item questionnaire developed by the WHO Adult ADHD Workgroup and published by Kessler et al. in 2005; the 6-item Part A screener is the clinically validated gateway and takes under five minutes to complete.
- Scoring 4 or more shaded responses on Part A indicates a high probability of adult ADHD consistent with a clinical diagnosis; the specific shading thresholds differ across the six items, so raw response count alone is not sufficient.
- The ASRS Part A has 99.5% specificity, meaning a positive result is very unlikely to be a false alarm; sensitivity is 68.7%, meaning roughly 1 in 3 people with ADHD may still screen negative and should not use a negative result to dismiss their concerns.
- A positive ASRS screen is a clinical starting point, not a diagnosis; formal adult ADHD assessment in Dubai involves a structured clinical interview, validated rating scales such as the DIVA-5, and cognitive evaluation to rule out overlapping conditions.
- Dubai clinics reported an elevenfold rise in adult ADHD self-referrals between 2021 and 2023, and a UAE university study found 34.7% of young adults screened positive for probable ADHD symptoms, underscoring how common undetected ADHD is in the region.
Fewer than 20% of adults with ADHD are accurately diagnosed and treated globally, according to a 2023 systematic review published in PMC. The gap between lived experience and clinical recognition is not mainly a matter of awareness; it is a matter of access to tools that can distinguish ADHD from the many other conditions that share its surface features. The ASRS ADHD screener, developed by the World Health Organization's Adult ADHD Workgroup and published by Kessler et al. in 2005, is the most widely validated first-line instrument for bridging that gap. It is brief, free, and built on large-scale epidemiological data. But knowing your score is only useful if you understand what the instrument is actually measuring, what its thresholds mean statistically, and what a positive result does and does not tell you.
This article is a detailed explainer of the ASRS instrument itself: its origins, structure, item-level scoring rules, and the clinical interpretation of its sensitivity and specificity figures. If you are looking for guidance on whether to screen, what the screening process involves, and how to take the next steps after a result, that pathway is covered in our article on adult ADHD self-screening in Dubai. This article focuses on the tool.
What is the ASRS and who developed it?
The Adult Self-Report Scale, universally abbreviated as the ASRS, was commissioned by the World Health Organization as part of its World Mental Health Survey Initiative. The scale was developed and validated by a research team led by Ronald C. Kessler at Harvard Medical School, working within the WHO International Consortium in Psychiatric Epidemiology. The validation study was published in 2005 in the International Journal of Methods in Psychiatric Research.
The purpose was deliberate and specific. By the early 2000s, it was well established that ADHD persists into adulthood for a substantial proportion of those diagnosed in childhood, and that many adults were reaching clinics for the first time having lived with unrecognised symptoms for decades. What clinicians lacked was a brief, psychometrically rigorous screening instrument they could deploy in busy primary care settings, occupational health contexts, or as a patient-completed first step before a specialist consultation. The ASRS was designed to fill exactly that role.
Critically, the ASRS is grounded in the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV at the time of development, since updated to DSM-5). Its 18 items correspond directly to the 18 DSM symptom criteria for ADHD, adapted into self-report language that reflects how those symptoms typically manifest in adult life rather than in childhood. A child criterion like "often runs about or climbs excessively" becomes, in the adult self-report version, a question about restlessness and difficulty sitting still in situations where it is expected.
The ASRS is free to use, publicly available, and has been translated and validated across multiple languages and cultural contexts. It is not proprietary to any clinical organisation, which is why it appears in settings as varied as Harvard's medical epidemiology research, Dubai private clinics, and NHS primary care in the UK. At CAYA World, we use the ASRS as the validated gateway into our adult ADHD assessment pathway, because its psychometric properties are the most thoroughly documented of any brief adult ADHD screener currently available.
The instrument comes in two versions: the full 18-item ASRS v1.1 and a condensed 6-item version known as Part A of the ASRS v1.1. When clinicians refer to the "ASRS screener," they almost always mean Part A. Understanding why requires knowing how the full scale is structured.
How does the ASRS v1.1 screener work? Structure, items, and the Part A rule
The ASRS v1.1 is divided into two sections. Part A contains 6 items. Part B contains the remaining 12 items. Both parts use the same 5-point response frequency scale: Never, Rarely, Sometimes, Often, Very Often. The respondent reads each item and selects the frequency that best describes how they have felt and conducted themselves over the past six months.
The 18 items map onto the two core symptom dimensions of ADHD. Items 1 through 9 address inattentive symptoms: difficulty sustaining attention on tasks, losing things, being easily distracted, struggling to follow through on instructions, avoiding tasks requiring sustained mental effort, and forgetting daily activities. Items 10 through 18 address hyperactive-impulsive symptoms: difficulty sitting still, feeling "on the go," talking excessively, blurting out answers, difficulty waiting, and interrupting others.
The reason Part A carries the clinical weight is empirical, not arbitrary. Kessler et al. ran an item-reduction analysis on the full 18-item scale to identify which subset of items maximised classification accuracy for a clinical ADHD diagnosis. The 6 items that form Part A were selected because, together, they produced the highest sensitivity and specificity combination of any subset tested. Part B items add clinical detail and are useful for a consulting clinician who wants a fuller symptom picture, but they do not meaningfully improve the screener's binary positive-or-negative classification. This is why a positive ASRS screen is defined entirely by the Part A score.
The 6 Part A items are:
- How often do you have trouble wrapping up the final details of a project, once the challenging parts have been done?
- How often do you have difficulty getting things in order when you have to do a task that requires organisation?
- How often do you have problems remembering appointments or obligations?
- When you have a task that requires a lot of thought, how often do you avoid or delay getting started?
- How often do you fidget or squirm with your hands or feet when you have to sit down for a long time?
- How often do you feel overly active and compelled to do things, like you were driven by a motor?
Notice that all six items reflect adult-adapted versions of DSM criteria. The "driven by a motor" phrasing, for example, directly echoes the DSM symptom criterion but is reframed so that an adult can recognise it as internal restlessness rather than visible running-around behaviour. At CAYA World, Dr. Nour Al Ghriwati frequently notes in clinical consultations that adult patients are often surprised that these items feel so precisely calibrated to their experience, having assumed that ADHD questionnaires would read like checklists designed for school-age children.
How to score the ASRS: the 4-or-more threshold explained
Scoring the ASRS Part A is not simply a matter of counting how many responses fall in the higher-frequency range. The shading threshold differs across the six items, and getting this detail wrong leads to misinterpretation of results. The scoring rule is as follows:
| Part A Item | Responses that count as positive |
|---|---|
| Item 1: Wrapping up final project details | Sometimes, Often, or Very Often |
| Item 2: Getting things in order / organising | Sometimes, Often, or Very Often |
| Item 3: Remembering appointments or obligations | Sometimes, Often, or Very Often |
| Item 4: Avoiding or delaying effortful tasks | Often or Very Often |
| Item 5: Fidgeting or squirming when seated | Often or Very Often |
| Item 6: Feeling driven by a motor / overly active | Very Often |
A response counts as "positive" on a given item only if it falls within the shaded threshold for that item. Items 1 through 3 have a lower threshold: "Sometimes" is enough to count. Items 4 and 5 require "Often" or "Very Often." Item 6 requires "Very Often." This graduated threshold reflects the empirically derived discriminating power of each item at different frequency levels. The behaviours in items 4 through 6 are common enough in the general population at moderate frequency that only high-frequency endorsement is clinically discriminating.
Once the item-level shading is applied, the total count of positive items is the Part A score. A score of 4 or more is a positive screen. A score of 0 to 3 is a negative screen. There is no intermediate category: the ASRS Part A produces a binary clinical signal, not a severity gradient. The full 18-item ASRS can provide a symptom-frequency profile that a clinician finds useful in planning an assessment, but the screening decision itself rests entirely on the Part A threshold.
You can complete the ASRS interactively using CAYA World's free online ADHD screener, which applies the correct item-level shading automatically and provides an immediate result with plain-language interpretation. This removes any ambiguity about which responses fall in the shaded zones.
What your ASRS score actually means and what it does not
The single most important thing to understand about an ASRS result is the distinction between screening and diagnosis. The ASRS is not a diagnostic instrument. It does not tell you whether you have ADHD. It tells you whether your self-reported symptom frequency pattern is consistent with the pattern seen in adults who do have ADHD, at a threshold calibrated to flag that consistency reliably.
A positive screen (4 or more on Part A) means your responses place you in a group whose symptom profile closely resembles that of clinically diagnosed adults with ADHD. The clinical interpretation, per Kessler et al. (2005), is that a positive result is "highly consistent with a diagnosis of ADHD" and warrants further clinical evaluation. It does not mean you definitely have ADHD. Other conditions, including anxiety disorders, depression, sleep disorders, and thyroid dysfunction, can produce symptom clusters that partially overlap with ADHD and that the ASRS was not designed to disentangle.
A negative screen (0 to 3 on Part A) means your responses do not meet the threshold pattern. This reduces the probability of an ADHD diagnosis, but it does not eliminate it. Because the ASRS has a sensitivity of 68.7%, roughly 31 in every 100 adults who do have ADHD will still screen negative. If you screened negative but continue to experience significant difficulties with attention, organisation, or impulse control, that result should not be the end of the inquiry. The next section explains exactly why.
At CAYA World, we treat the ASRS result as one piece of data in an initial consultation, not as a gating criterion. Adults who screen negative but present with a compelling history of functional impairment still proceed to full clinical evaluation, because the instrument's sensitivity limitation is clinically meaningful. Conversely, a positive screen does not accelerate straight to an ADHD diagnosis: it opens the door to structured assessment that explores the full differential picture.
If you have concerns about your child's attention or executive functioning, the assessment pathway differs from the adult process. Our psychoeducational testing service in Dubai covers the range of instruments used for children and adolescents, where parent and teacher rating scales complement the clinical interview in ways the adult self-report model does not.
If you have already completed an ASRS screen and are weighing whether to pursue a full evaluation, the decision framework is covered step by step in our guide to adult ADHD self-screening in Dubai. The present article focuses specifically on what the instrument itself is measuring and why the numbers mean what they mean.
If you scored 4 or more on Part A and want to understand whether a formal assessment is the right next step for you, our clinical team at CAYA World can walk you through the process in a brief intake conversation. Our adult ADHD assessment service is designed precisely for this point in the process.
Wondering if It's Time to Talk to Someone?
Our specialist team at CAYA World offers comprehensive assessment and evidence-based treatment, conducted from our clinic in Palm Jumeirah, Dubai.
Sensitivity, specificity, and why the ASRS is better at ruling in than ruling out
The two statistics that matter most when evaluating any screening instrument are sensitivity and specificity. These terms are often treated as interchangeable in lay discussion, but they describe two entirely different properties of a test, and the ASRS's profile on these two dimensions has direct, practical implications for how you should interpret your result.
Sensitivity measures how well the test identifies people who actually have the condition. A sensitivity of 68.7% means that if you gathered 100 adults who had been comprehensively assessed and confirmed to have ADHD, approximately 69 of them would score 4 or more on the ASRS Part A (true positives). The remaining 31 would score 3 or below (false negatives). Those 31 adults have ADHD, but the ASRS would not flag them.
Specificity measures how well the test identifies people who do not have the condition. A specificity of 99.5% means that if you gathered 100 adults confirmed not to have ADHD, approximately 99 or 100 of them would score below the threshold (true negatives). Only about 1 in 200 people without ADHD would produce a positive screen (false positive). This is an exceptionally high specificity for a self-report screener.
The practical asymmetry this creates is significant. When you test positive, you can be very confident the signal is real. The false positive rate is so low (0.5%) that a positive ASRS result almost always reflects genuine symptom elevation. When you test negative, you have reduced the probability of ADHD, but you have not excluded it: the 31.3% false negative rate is substantial enough that a negative screen in the context of significant functional difficulty should not be taken as reassurance.
The overall classification accuracy of the ASRS Part A is 97.9%, with a kappa of 0.76, which represents strong agreement between the screener and a structured clinical diagnosis (Kessler et al., 2005). That figure, however, is driven primarily by the high specificity and reflects the fact that ADHD is not universal in the general population: in any sample, the majority of people do not have ADHD, so a highly specific test will correctly classify most of the sample by virtue of correctly ruling out the majority who are unaffected.
This statistical profile means the ASRS was designed and calibrated primarily as a rule-in tool rather than a rule-out tool. A positive screen is a strong signal warranting clinical follow-up. A negative screen is weaker evidence in the other direction. Clinicians familiar with this profile use the ASRS accordingly: a positive result moves the needle substantially toward further evaluation; a negative result informs but does not close the clinical picture.
Understanding this asymmetry also explains why a comprehensive adult ADHD assessment cannot be replaced by repeated self-screening. Globally, fewer than 20% of adults with ADHD are accurately diagnosed and treated, according to a 2023 systematic review (PMC, 2023). Many of those undiagnosed individuals have likely taken self-report tools at some point and either interpreted a negative screen as definitive or not known where to take a positive screen next. The ASRS is a gateway, and its clinical value is realised only when it connects to a structured pathway.
From ASRS screener to formal adult ADHD assessment in Dubai
Dubai's clinical landscape for adult ADHD has shifted dramatically in recent years. According to a 2024 report in The National, Dubai clinics documented an elevenfold rise in adult self-referrals for ADHD assessment between 2021 and 2023, with women representing the majority of new intakes. A 2023 peer-reviewed study by Al-Omari et al., published in the Journal of Epidemiology and Global Health, found that 34.7% of a UAE university sample of 406 young adults (aged 18 to 20) screened positive for probable ADHD symptoms, though the authors noted that comprehensive national prevalence data for adult ADHD in the UAE remains absent from the published literature.
Globally, persistent adult ADHD affects an estimated 2.58% of adults (approximately 139.84 million people), while symptomatic presentations including subthreshold cases extend that figure to an estimated 6.76%, or roughly 366 million adults worldwide (Faraone et al., 2021). Both figures underscore the scale of unmet diagnostic need and contextualise why structured screening tools like the ASRS matter.
In the Dubai clinical context, a positive ASRS screen is the starting point for a pathway that typically involves several structured components. The first step is a clinical consultation with a psychologist, during which the self-report data is reviewed alongside a developmental history. ADHD is a neurodevelopmental condition by DSM-5 definition, which means some symptoms must have been present before age 12, even if they were not identified or labelled at the time. Establishing this history is a core part of the assessment that no self-report instrument can replicate.
The second component is a structured clinical interview using a validated tool designed specifically for adult ADHD. At CAYA World, our clinical team uses the Diagnostic Interview for ADHD in Adults (DIVA-5), which operationalises every DSM-5 criterion for ADHD into an interviewer-administered format, covering both current symptoms and retrospective childhood evidence across work, home, and social domains.
The third component, where clinically indicated, is cognitive and neuropsychological testing. This is relevant when the presenting picture is complex: when there is meaningful overlap with anxiety or depression, when the person's history suggests a learning difficulty such as dyslexia may be contributing to attention difficulties, or when the assessment is being conducted for purposes such as workplace accommodation documentation. Our adult ADHD assessment service at CAYA World integrates all three components and produces a clinical report that is recognised by DHA-licensed practitioners for onward management, including psychiatric referral for medication evaluation if that is the appropriate next step.
For adults in Dubai who are at the beginning of this process, taking the ASRS is a practical and evidence-based first step. The instrument's high specificity means that if it flags you, that flag is credible. What comes next is not a repeat of the same self-report in different packaging; it is a systematic clinical evaluation that the ASRS has initiated but cannot complete.
Frequently Asked Questions About the ASRS ADHD Screener in Dubai
A score of 4 or more on Part A is a positive screen, which Kessler et al. (2005) describe as "highly consistent with a diagnosis of ADHD." It means your symptom frequency pattern closely resembles that of adults who have received a clinical ADHD diagnosis. It does not confirm ADHD on its own. Several conditions, including anxiety, depression, sleep disorders, and thyroid problems, can produce overlapping symptom profiles. A positive ASRS result should prompt a formal clinical evaluation rather than a self-diagnosis.
The full ASRS v1.1 has 18 items corresponding to all 18 DSM ADHD symptom criteria. Part A (the screener) consists of the 6 items identified through statistical analysis as having the highest combined sensitivity and specificity for clinical ADHD diagnosis. Part B's 12 additional items provide a fuller symptom frequency picture but do not improve the binary positive-or-negative screening decision. Clinicians typically use Part A for screening and the full 18-item version to map the broader symptom profile during assessment.
No. The ASRS is a screening instrument, not a diagnostic one. In Dubai, an ADHD diagnosis is made by a licensed psychologist or psychiatrist following a comprehensive evaluation that includes clinical interview, developmental history, validated structured tools such as the DIVA-5, and, where indicated, cognitive testing. The ASRS result can be brought to your first clinical appointment as useful preliminary data, but it does not replace any component of the formal diagnostic process.
A positive ASRS screen is a prompt to book a clinical consultation with a specialist in adult ADHD assessment. At that appointment, the psychologist will review your ASRS responses alongside a structured clinical interview covering current symptoms, developmental history, and functional impairment across work, home, and social settings. If the clinical picture supports it, the evaluation proceeds to comprehensive assessment using validated tools such as the DIVA-5. The process at CAYA World typically spans two to three sessions, after which a diagnostic report is produced if criteria are met.
The ASRS Part A has a specificity of 99.5%, meaning false positives are very rare: fewer than 1 in 200 people without ADHD will screen positive. Sensitivity is 68.7%, meaning approximately 31 in 100 adults with ADHD will screen negative (false negatives). This makes the ASRS considerably better at ruling ADHD in than at ruling it out. A positive result is a strong, reliable signal. A negative result reduces the probability of ADHD but does not exclude it, particularly in adults who experience significant functional difficulties consistent with ADHD symptoms.
Sources and Further Reading
- The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general populationKessler RC et al., International Journal of Methods in Psychiatric Research (2005)
- The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorderFaraone SV et al., Neuroscience and Biobehavioral Reviews (2021)
- Prevalence of attention deficit hyperactivity disorder among university students in the UAEAl-Omari H et al., Journal of Epidemiology and Global Health (2023)
- Dubai clinics report surge in ADHD cases among women as silent struggle continuesThe National (2024)
- Global prevalence of ADHD in adults: systematic review and meta-analysisPMC Systematic Review (2023)
- Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Association (2013)